Summary Results are reported on the sensitivity of various gynaecological tumour cell lines to 5-aminolaevulinic acid-induced protoporphyrin IX-sensitised photodynamic therapy (ALA-PDT) in vitro. All cell lines tested accumulated ALA-induced protoporphyrin IX (PpIX) and demonstrated good sensitivity to ALA-PDT. Localisation of PpIX in the mitochondria was demonstrated by fluorescence microscopy. Subcellular damage following ALA-PDT was observed using transmission electron microscopy. This damage was localised initially to the mitochondria, with damage to membranes and the nucleus and complete loss of intracytoplasmic organisation being observed subsequently. There was no apparent difference in ALA-PDT response between a multidrug-resistant ovarian carcinoma cell line and its parent line. These results indicate that ALA-PDT has potential for application to therapy of gynaecological malignancies.
5-aminolaevulinic acid
Gynaecological malignancies represent a challenge to the medical community. The incidence of preinvasive squamous carcinoma has risen dramatically over the past decade and it has been predicted that mortality caused by cervical carcinoma will increase 20% by the year 2000 unless significant improvements in screening techniques are achieved (Beral and Booth, 1986) . While the response to surgery, radiotherapy and chemotherapy is relatively good for early stages of the disease, there is a high mortality rate in advanced, multifocal or recurrent cancers (Corti et al., 1987; Cannistra, 1993) . The vast majority of patients with advanced ovarian cancer die of the disease (Ozols and Young, 1991) , with overall survival rates not improving over the last 20 years. Further, the current clinical approaches to treatment are not suitable for all patients, especially for elderly women. Photodynamic therapy (PDT) is an alternative approach to cancer treatment that has, in the last 20 years, yielded very encouraging results (Dougherty and Marcus, 1992) . This technique involves the administration of a non-toxic dose of a photosensitising compound that is selectively retained by malignant tissues. Light in the visible range of the electromagnetic spectrum is then used to activate the drug in situ. This activated drug initiates a series of chemical reactions that leads to the selective destruction of the malignant tissues. This promising new treatment modality has already been used clinically for the experimental detection and treatment of various types of tumour, including bladder, oesophagus, skin, lung and gynaecological malignancies (Dougherty and Marcus, 1992) . The combination of surgery with PDT offers a number of advantages when compared with chemotherapy. No intrinsic resistance to PDT, general toxicity or cumulative toxicity has been observed to date. The short half-life of the cytotoxic species and the mechanism of action of PDT ensure that the damage is localised primarily to the malignant tissues, sparing adjacent normal tissues. There is no reported risk of mutagenesis. PDT generally requires fewer treatments than radiation therapy, is costeffective and is relatively non-invasive (Levy, 1994) . It can be performed following debulking of large tumours during excisional surgery.
The clinically most widely used photochemotherapeutic reagent to date has been photofrin (PF, porfimer sodiumR, photofrin II), along with several similar preparations such as dihaematoporphyrin ether (DHE), haematoporphyrin derivative (HpD) and polyhaematoporphyrin (PHP) . Phase III studies in the USA with PF have focused on obstructive tumours of lung and oesophagus (Levy, 1994) . The use of PDT in gynaecological lesions has provided encouraging results in preliminary studies (Corti et al., 1987; DeLaney et al., 1993 and references therein) . For example, DeLaney reports phase I clinical trials using combined debulking surgery and DHE-PDT for disseminated intraperitoneal tumours. In Japan, PF has been used on cervical carcinoma in situ with a 94% complete response rate (Kato et al., 1993) . To date, PF has been approved for photochemotherapeutic treatment of the following malignancies: cervical (Japan), superficial bladder (Canada), oesophageal (Canada and The Netherlands), stomach (Japan) and lung (Japan and The Netherlands).
PF-PDT shows a useful degree of specificity for many malignant tissues, but the slow clearance rate of PF from normal tissues leads to prolonged skin photosensitivity (several weeks to several months). It is necessary therefore to wait at least several weeks between treatments to permit drug clearance and maintain the original level of tissue specificity. Current protocols for PF are limited to a total of three treatments. The search for other photosensitisers with more suitable properties is ongoing (Dougherty and Marcus, 1992 ).
An effective alternative to PF-PDT involves the use of the endogenous photosensitiser protoporphyrin IX (PpIX) (Kennedy and Pottier, 1992) , which is induced to accumulate by administration of its metabolic precursor 5-aminolaevulinic acid (ALA). Administration of ALA bypasses the feedback control system in the haem biosynthetic pathway, resulting in cellular/tissue accumulation of photosensitising amounts of PpIX. Although PpIX biosynthesis is an active pathway in all nucleated cells, preferential formation/ accumulation of PpIX has been demonstrated in malignant tissues (Batlle, 1993; Kennedy and Pottier, 1994) . ALA-PDT has been used previously on a variety of normal and malignant cell types in vitro (Malik and Lugaci, 1987; linuma et al., 1994) (Kennedy and Pottier, 1994; Cairnduff et al., 1994; Gossner et al., 1995; Lang et al., 1995; Lui et al., 1995; Mlkvy et al., 1995; Regula et al., 1995) .
Previously there have been few reports of gynaecological applications of ALA-PDT. It has been used for endometrial ablation and to prevent embryonic implantation in laboratory animals (Yang et al., 1993 (Yang et al., , 1994 (Yang et al., , 1995 Wyss et al., 1994 (Falcon) . Accumulation of protoporphyrin IX (PpIX) fluorescence induced by ALA was assessed by an EPICS Elite flow cytometer (Coulter Electronics, Burlington, Ontario, Canada) as previously described (Campbell et al., 1996) . This method allowed the individual examination of the fluorescence emitted by several thousands of cells (n>5000). The 488 nm line of an argon ion laser was used as an excitation source (at a power of 100 mW), and a 630/20 nm bandpass (BP) (20 nm full width half maximum) filter was placed on the emission side in order to isolate the PpIX fluorescence signal. DNA-Check beads (Coulter Electronics) were used to standardise the system and minimise variability between experiments. The autofluorescence of the control sample was subtracted from the mean fluorescence intensity of each sample and these values were expressed in arbitrary fluorescence units. The data were not corrected for differences in cell volume as all of the cell lines had similar volumes as assessed by the measurement of the forward scatter on the flow cytometer (Campbell et al., 1996) .
Spectroscopy
Cell samples were incubated with ALA and pelleted as described above. Fluorescence emission and excitation spectra were obtained from the pellets, using a fluorimetry system described elsewhere (Dickson et al., 1995) . To obtain emission spectra, excitation light from a Xe lamp filtered through a 410/10 nm BP filter was directed through one arm of a bifurcated fibre bundle onto the sample. The fluorescence was collected through the other arm of the bifurcated fibre bundle and sent to a linear diode array spectrophotofluorometer which recorded the entire emission spectrum through a 535 nm long pass (LP) filter. To obtain excitation spectra, a filter was placed on the excitation side which passed 400-650 nm; emission through a 710/10 nm BP filter was quantified while scanning the excitation wavelength, using a stepping monochromator, every 5 nm between 350 and 670 nm. The excitation spectra were corrected for excitation intensity.
Cell photosensitisation Cells, incubated with ALA as previously described, were light-treated with a tungsten lamp equipped with a heat filter and a 600-700 nm BP filter. The photosensitising light was focused perpendicularly on the cell culture well, which was placed on a rotating holder to ensure uniformity of irradiation (irradiance 70 + 10 mW cm-2), determined using an apertured calorimetric detector (Sciencetech 380101, Boulder, CO, USA). After a predetermined time of light exposure, cells were collected and labelled with fluorescent dyes in order to assess cell viability by flow cytometry as described elsewhere (Campbell et al., 1996) 883 localisation studies, the cells on the coverslips were further incubated for 10 min in 10 jug ml-' rhodamine 123 in RPMI (without phenol red), rinsed in RPMI without phenol red, then observed as previously described through a 525/30 nm BP filter. The no ALA and no rhodamine controls exhibited no cross-fluorescence under the experimental conditions used.
Electron microscopy Cells were incubated with ALA, irradiated (when required) and collected as previously described. Cells were centrifuged (1 min, 12 000 r.p.m.), fixed in 2% paraformaldehyde-0.5% glutaraldehyde in 0.2 M cacodylate buffer, post-fixed in 1% osmium in 0.1 M cacodylate buffer for 1 h, dehydrated in ethanol and embedded in epon 812 (epoxy resin). Thin sections (70 nm) were stained with uranyl acetate and lead citrate and then observed in a Hitachi H500 transmission electron microscope (TEM). Figure 1 shows that the emission and excitation spectra observed from the A2780-9S cell pellets correspond to those of PpIX. No fluorescence emission spectrum characteristic of other endogenous porphyrins was observed. Similar results were obtained for all of the cell lines studied.
Results

ALA-induced accumulation of PpIX
After dark incubation with ALA, all the cell lines studied showed some degree of porphyrin accumulation, with a broad histogram of fluorescence intensities. Figure 2 shows that the accumulation of PpIX, as judged by the PpIX fluorescence intensity, increased with the time of dark incubation, and tended towards a plateau after 5 h for most cell lines. However, in no case was an actual plateau reached for incubation times up to 28 h. Only the A2780-9S cells appear to accumulate PpIX at linearly increasing concentrations for up to 28 h. Figure 3 shows that at concentrations of ALA lower than 2.5 mM, PpIX accumulation appeared to be dose dependent, but all cell lines showed an accumulation plateau for concentration of ALA greater than 5 mM. At higher ALA doses (10 mM) there was, for the A2780-9S and SiHa cells, a small decrease in accumulation, possibly owing to the acidity of the ALA solution exceeding the buffer capability of the medium. Based on the above results, a concentration of ALA corresponding to the plateau region of the PpIX accumulation vs ALA concentration curves (5 mM) was used for all further experiments.
ALA-induced photosensitisation
After incubation with ALA, the cells became very sensitive to light-induced damage. mitochondria [Rhodamine is a known stain for mitochondria (Shapiro, 1994) ]. The location of subcellular phototoxic damage was studied by transmission electron microscopy. TEM pictures taken after cell incubation with ALA and different doses of light showed diffuse mitochondrial alterations as an early phenomenon ( Figure 6 ), with mitochondria swollen and showing enlarged intercristae spaces. At higher light doses (Figure 7 ), vacuolisation and vesiculation of the cytoplasm, condensation of the nuclear chromatin, swelling of the nuclear membrane and rounding of the cellular shape were observed. At even later stages the integrity of the cytoplasmic membrane and the cytoplasmic structure was lost and the nuclei appeared pycnotic.
Discussion
Results obtained in this in vitro study clearly show that cell lines derived from gynaecological tumours can accumulate ALA-induced PpIX, exhibiting a significant degree of PpIX fluorescence. There is a significant correlation between ALA incubation time, that is, the amount of PpIX accumulation, and efficacy of ALA-PDT, as judged by the survival curves. A minimum of three logs of cell kill can be obtained by ALA-PDT at doses > 15 J cm-2 of red light for larger amounts of accumulated PpIX. Although in vitro work on cell lines cannot be extrapolated directly to in vivo systems, these results, along with other preliminary results obtained in our laboratory on surgical specimens, indicate that ALAinduced PpIX may be useful in the detection and treatment of gynaecological tumours. ALA-PDT has been used to treat an ovarian carcinoma metastatic in the vaginal vault, which showed a good clinical response with adequate tissue specificity (JC Kennedy, unpublished results).
For detection purposes, HpD fluorescence has been a useful tool, showing good correlation with histological findings in delineating the limits of cervical lesions (Gray et al., 1967; Kyriazis et al., 1973) . PpIX fluorescence has been used in the same manner, for example in the bladder (Svanberg et al., 1993; Kriegmair et al., 1994) , and should find clinical usefulness in detection of metastatic gynaecological tumours also.
Drug resistance is a serious problem for conventional chemotherapy and has been reported also for PDT using photofrin in tissue culture. Cell lines resistant to PF-PDT have also shown cross-resistance to other therapeutic methods. Chinese hamster ovary fibroblast multidrugresistant (CHO-MDR) cells have shown cross-resistance to PF-PDT (Singh et al., 1991; Mitchell et al., 1988) . In this case tion of cytoplasm, rupture of cytoplasmic membrane and loss of cytoplasmic structure, swelling of the nuclear membrane and nuclear pycnosis. These phenomena were seen in all cell types multidrug resistance conferred some degree of PF-PDT resistance but the converse was not true. In contrast, a MDR human breast cancer line was not PF-PDT resistant (Mitchell et al., 1988) . PF-PDT-resistant radiation-induced fibrosarcoma (RIF) cells have shown cross-resistance to cisplatin, but do not exhibit multidrug resistance (Moorehead et al., 1994) . Mouse tumour cells resistant to PF-PDT also did not exhibit a multidrug resistance phenotype nor did they have altered porphyrin uptake properties (Luna and Gomer, 1991) . Explanations for these various observations include altered subcellular localisation of photosensitiser, photodamage repair mechanisms or plasma and mitochondrial membrane potentials, with different mechanisms existing in general for PF-PDT-and multidrug-induced resistance. Possible mechanisms for drug resistance in general include, for example, altered drug transport (implicated in multidrug resistance), increased metallothionein or glutathione levels, altered DNA adduct formation and/or repair and altered membrane potentials. For ALA-PDT, our data indicate that there is no significant difference in response between the doxorubicin-resistant (MDR) ovarian cell line 2780AD and its doxorubicin-sensitive parental cell line. Thus, at least in these cells, multidrug resistance does not appear to confer any resistance to ALA-PDT. We have also demonstrated that cisplatin-resistant small-cell lung cancer cells do not show resistance to ALA-PDT (Campbell et al., 1995) .
The mechanisms for accumulation and the sites of phototoxic damage are different for ALA-induced PpIX (this study and linuma et al., 1994) and PF (Schneckenburger et al., 1988; Berns et al., 1982; Moan et al., 1989; Salet and Moreno, 1990; Kessel, 1986) . PF passes from the extracellular environment into the plasma membrane, and from there is believed to migrate to various intracellular sites including the nuclear and mitochondrial membranes. Various transport processes must be involved and sites of action can be different depending on the delivery method. On the other examined.
hand, since the PpIX is synthesised largely in the mitochondria (Batlle, 1993) , no PpIX transport is required before accumulation in the location sensitive to damage. Mitochondrial alterations suggest that this organelle is in fact a primary site of ALA-PDT damage. TEM results obtained in this study are similar to those previously reported on cells incubated with haematoporphyrin (Milanesi et al., 1989; Malik et al., 1992) , ALA (Malik and Lugaci, 1987) and PF (Evensen et al., 1988; Leunig et al., 1994; Ning and Pan, 1985) . Observations common to all cell lines studied included swollen mitochondria, loss of microvilli and vacuolisation and vesiculation of the cytoplasm. Also observed are the enlargement of the nuclear membrane, probably owing to influx of water in the inner space as the two membranes are still connected at the level of the nuclear pores, and rupture of the plasma membrane leading to complete loss of intracytoplasmic organisation. Nuclear alterations included condensation of the chromatin and a pycnotic appearance of the nuclei. From the flow cytometric data obtained at various light doses (not shown), it can be seen that at low doses of light, early damage is manifested as increased permeability of the plasma membrane (decrease in the calcein fluorescence) without a concomitant increase in ethidium fluorescence; at higher light doses nuclear membrane permeability increases (increase in ethidium fluorescence). This suggests that nuclear alterations are the consequence of an indirect process, which may imply a Ca2+ imbalance resulting in activation of endonucleases.
While several questions on the detailed mechanism of ALA-PDT mode of action still remain to be solved, our results indicate that ALA planned to evaluate the clinical potential of this phenomenon.
To date, good clinical responses have been seen in preliminary patient studies of ALA-PDT in breast secondaries in the chest wall (Kennedy and Pottier, 1992) 
